Packages (Simulation)
Reagent Preparation
Image (I)
Certificate
CLIA Kit for Angiotensin I (AngI)
Ang-I; Angiotensin-1
- Product No.CCA811Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates, cell culture supernates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range7.81-2,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 2.92pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 588
For more details, please contact local distributors! US$ 840 US$ 3780 US$ 7140 US$ 58800
Specificity
This assay has high sensitivity and excellent specificity for detection of Angiotensin I (AngI).
No significant cross-reactivity or interference between Angiotensin I (AngI) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Angiotensin I (AngI) and the recovery rates were calculated by comparing the measured value to the expected amount of Angiotensin I (AngI) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 83-93 | 89 |
EDTA plasma(n=5) | 95-103 | 99 |
heparin plasma(n=5) | 88-102 | 96 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Angiotensin I (AngI) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Angiotensin I (AngI) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Angiotensin I (AngI) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 89-101% | 87-94% | 79-92% | 98-105% |
EDTA plasma(n=5) | 80-98% | 94-104% | 95-104% | 79-101% |
heparin plasma(n=5) | 94-101% | 89-104% | 78-95% | 82-99% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
Substrate A | 1×10mL | Substrate B | 1×2mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
7. Read RLU value immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Inflammopharmacology | Evening primrose oil and celecoxib inhibited pathological angiogenesis, inflammation, and oxidative stress in adjuvant-induced arthritis: novel role of angiopoietin-1 Pubmed: 24664592 |
Clinical Nutrition | Protein malnutrition impairs bone marrow endothelial cells affecting hematopoiesis Pubmed: 31326233 |
Journal of Alzheimers Disease | Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease Pubmed: 31594235 |
Dikkat Eksikliği Hiperaktivite Bozukluğu Tanısı Olan Anjiyotensin I, II, III, Alamandin peptid, Anjiyotensin Dönüştürücü Enzim (ACE), NADPH Oksidaz Enzim Serum … | |
The Effect of Angiotensin-Converting Enzyme Gene Polymorphisms in the Coronary Slow Flow Phenomenon at South Sumatra, Indonesia Population |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA811Hu01 | Recombinant Angiotensin I (AngI) | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA811Hu21 | OVA Conjugated Angiotensin I (AngI) | Immunogen; SDS-PAGE; WB. |
PAA811Hu01 | Polyclonal Antibody to Angiotensin I (AngI) | WB; IHC; ICC; IP. |
LAA811Hu71 | Biotin-Linked Polyclonal Antibody to Angiotensin I (AngI) | WB; IHC; ICC. |
CEA811Hu | ELISA Kit for Angiotensin I (AngI) | Enzyme-linked immunosorbent assay for Antigen Detection. |
CCA811Hu | CLIA Kit for Angiotensin I (AngI) | Chemiluminescent immunoassay for Antigen Detection. |
LMA811Hu | Multiplex Assay Kit for Angiotensin I (AngI) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
KSA811Hu11 | ELISA Kit DIY Materials for Angiotensin I (AngI) | Main materials for "Do It (ELISA Kit) Yourself". |